Article
Mirati's lung cancer drug gets EU's regulatory backing
Rating:
0.0
Views:
30
Likes:
1
Library:
1
Mirati Therapeutics said on Friday the European medicines regulator's panel has recommended approval of its treatment for a type of lung cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value